PemBla: a Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer
<p><strong>Objectives:</strong> This study aimed to investigate the anti-PD-1 inhibitor pembrolizumab as a potential agent for use in non-muscle-invasive bladder cancer (NMIBC) by conducting a Phase 1 safety run-in study to assess the safety and tolerability of intravesical pembrol...
Main Authors: | Woodcock, VK, Chen, J-L, Purshouse, K, Butcher, C, Collins, L, Haddon, C, Verrall, G, Elhussein, L, Roberts, C, Tarlton, A, Rei, M, Napolitani, G, Salio, M, Middleton, MR, Cerundolo, V, Crew, J, Protheroe, AS |
---|---|
格式: | Journal article |
語言: | English |
出版: |
Wiley
2023
|
相似書籍
-
PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non‐muscle‐invasive bladder cancer
由: Victoria K. Woodcock, et al.
出版: (2023-05-01) -
Abiraterone acetate in combination with prednisone in the treatment of metastatic hormone-sensitive prostate cancer: clinical evidence and experience
由: Karin Purshouse, et al.
出版: (2019-01-01) -
The role of invariant natural killer T (iNKT) cells in modulating the lung inflammatory response during influenza A virus infection
由: McEwen-Smith, R, et al.
出版: (2013) -
P105 (0032) A PHASE II STUDY OF PEMBROLIZUMAB (PEM) FOLLOWED BY AVD FOR FRONTLINE TREATMENT OF CLASSICAL HODGKIN LYMPHOMA (CHL): INTERIM RESULTS
出版: (2018-10-01) -
Intravesical protrusion of giant median prostatic lobe: A case report
由: M. Duijn, et al.
出版: (2022-09-01)